scispace - formally typeset
Open AccessJournal ArticleDOI

Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: Gastric bipartition, a novel metabolic surgery procedure: A retrospective cohort study.

Reads0
Chats0
TLDR
SASI bypass is a promising operation that offers excellent weight loss and diabetic resolution and is a therapeutic option for obese T2DM patients.
About
This article is published in International Journal of Surgery.The article was published on 2016-10-01 and is currently open access. It has received 71 citations till now. The article focuses on the topics: Sleeve gastrectomy & Anastomosis.

read more

Citations
More filters
Journal ArticleDOI

IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures.

TL;DR: There was an increase in the total number both of surgical and endoluminal bariatric/metabolic procedures performed worldwide in 2016 and the surgical trends from 2008 to 2016.
Journal ArticleDOI

Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement

TL;DR: Standard versions of the finished anatomic configurations of 22 surgical procedures were established by expert consensus, as a first step in developing evidence-based standard bariatric metabolic surgical procedures with the aim of improving consistency in surgery, data collection, comparison of procedures, and outcome reporting.
Journal ArticleDOI

Evaluation of the Efficacy of Single Anastomosis Sleeve Ileal (SASI) Bypass for Patients with Morbid Obesity: a Multicenter Study.

TL;DR: The SASI bypass is an effective bariatric and metabolic surgery that achieved satisfactory weight loss and improvement in medical comorbidities, including T2DM, hypertension, sleep apnea, and GERD, with a low complication rate.
Journal ArticleDOI

Single anastomosis sleeve ileal (SASI) bypass versus sleeve gastrectomy: a case-matched multicenter study

TL;DR: Both procedures had similar weight loss at 6 months postoperatively and comparable complication rates and SASI bypass conferred better improvement in T2DM and GERD than SG.
Journal ArticleDOI

1-Year Follow-up of Single Anastomosis Sleeve Ileal (SASI) Bypass in Morbid Obese Patients: Efficacy and Concerns

TL;DR: SASI bypass is a newly introduced investigational procedure for improving weight loss and comorbidities; however, it may result in EWL and protein malnutrition and should only be performed for select patients and by well-experienced bariatric surgeons.
References
More filters
Journal ArticleDOI

Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat Obesity and Associated Diseases

TL;DR: Based on physiological and supported by evolutionary data, this procedure creates a proportionally reduced gastrointestinal (GI) tract that amplifies postprandial neuroendocrine responses and leaves basic GI functions unharmed.
Journal ArticleDOI

Laparoscopic adjustable silicone gastric banding: complications.

TL;DR: While improvements in surgical technique may decrease early technical complications such as gastric prolapse, long-term follow-up studies will be required to determine the ultimate success of this device in controlling severe obesity.
Journal ArticleDOI

Peripheral signals in the control of satiety and hunger.

TL;DR: A better understanding of these systems and how they relate to body adiposity will prove to have important clinical applications and suggest that interventions directed at multiple targets in the energy homeostasis system may be necessary to achieve and maintain weight loss.
Journal ArticleDOI

The neuroendocrinology of obesity

TL;DR: As the nosology of obesity improves, diagnostic efficiency and therapeutic success should increase, leading to a decrease in associated morbidity, mortality, and socioeconomic ramifications.
Journal ArticleDOI

Slowing intestinal transit by PYY depends on serotonergic and opioid pathways

TL;DR: The hypothesis that the slowing of intestinal transit by PYY depends on an ondansetron-sensitive serotonergic pathway and a naloxone-sensitive opioid pathway is tested, demonstrating a key role for this gut peptide.
Related Papers (5)